Management of Chronic Constipation in Special Situations
For chronic constipation in special populations like pregnancy, older adults, and those with neurological conditions, polyethylene glycol (PEG) is the first-line pharmacological treatment, which can be combined with psyllium fiber supplements for enhanced effect. 1, 2
Pregnancy
First-line approach
- Lactulose is the only osmotic agent specifically studied in pregnancy and should be preferred (15g daily) 1
- Increase dietary fiber (aim for 14g/1000 kcal) and fluid intake
- Magnesium oxide can be used with caution (400-500mg daily) 1
Second-line approach
- Stimulant laxatives (senna 8.6-17.2mg daily) may be used for short-term relief
- Avoid bisacodyl for long-term use during pregnancy due to limited safety data
Cautions
- Monitor for adequate hydration, especially with fiber supplementation
- Avoid lubiprostone as it may cause fetal loss based on animal studies 3
Older Adults
First-line approach
- PEG (17g daily) is particularly effective in older adults with fewer side effects 1, 4
- Fiber supplementation should be started at low doses and gradually increased to minimize bloating and discomfort 4
Second-line approach
- Osmotic laxatives: lactulose or magnesium oxide (avoid magnesium in renal insufficiency) 1, 4
- Stimulant laxatives (bisacodyl 5mg daily or senna) for short-term use or rescue therapy 1
- Elderly patients experience lower rates of nausea with lubiprostone compared to younger adults (19% vs 29%) 3
Special considerations
- Review medication list for constipating drugs (opioids, anticholinergics, calcium channel blockers) 4, 5
- Screen for impaction before escalating therapy 2
- Consider prescription medications for refractory cases:
Neurological Conditions
First-line approach
- PEG combined with psyllium fiber supplements 2
- Increase fluid intake and dietary fiber (>10g/day for at least 4 weeks) 2
- Consider fractionating meals in patients with muscular fatigue 2
Second-line approach
- Osmotic laxatives (magnesium oxide or lactulose) 2
- Stimulant laxatives (bisacodyl or senna) for rescue therapy 2
- Prucalopride has strong recommendation for use in neurological conditions 1, 2
Refractory constipation
- Prescription medications: linaclotide, plecanatide, or lubiprostone 1, 2
- Rectal interventions may be necessary:
Common Pitfalls and Caveats
Inadequate hydration: Always ensure adequate fluid intake when increasing fiber to prevent worsening constipation 1, 2
Inappropriate use of magnesium: Avoid in patients with renal insufficiency due to risk of hypermagnesemia 1, 2
Missing underlying causes: Rule out impaction or mechanical obstruction before escalating therapy 2
Overlooking medication side effects: Review and discontinue non-essential constipating medications 2
Inappropriate dosing in hepatic impairment: Adjust dosage of lubiprostone in patients with moderate to severe hepatic impairment 3
Prolonged use of stimulant laxatives: Long-term safety and efficacy are unknown; use for short-term or rescue therapy when possible 1
Inadequate fiber titration: Slowly increase fiber intake over several weeks to minimize adverse effects like bloating and abdominal discomfort 4
By following these population-specific approaches and avoiding common pitfalls, chronic constipation can be effectively managed in these special situations, improving patient quality of life and preventing complications.